186 related articles for article (PubMed ID: 31113002)
21. Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients.
Müller vom Hagen J; Karle KN; Schüle R; Krägeloh-Mann I; Schöls L
Eur J Neurol; 2014 Jul; 21(7):983-8. PubMed ID: 24698313
[TBL] [Abstract][Full Text] [Related]
22. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
Parikh S; Bernard G; Leventer RJ; van der Knaap MS; van Hove J; Pizzino A; McNeill NH; Helman G; Simons C; Schmidt JL; Rizzo WB; Patterson MC; Taft RJ; Vanderver A;
Mol Genet Metab; 2015 Apr; 114(4):501-515. PubMed ID: 25655951
[TBL] [Abstract][Full Text] [Related]
23. Inborn errors of brain myelin formation.
Boespflug-Tanguy O
Handb Clin Neurol; 2013; 113():1581-92. PubMed ID: 23622380
[TBL] [Abstract][Full Text] [Related]
24. POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches.
Perrier S; Michell-Robinson MA; Bernard G
Front Cell Neurosci; 2020; 14():631802. PubMed ID: 33633543
[TBL] [Abstract][Full Text] [Related]
25. Precision Medicine for Lysosomal Disorders.
Pinto E Vairo F; Rojas Málaga D; Kubaski F; Fischinger Moura de Souza C; de Oliveira Poswar F; Baldo G; Giugliani R
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722587
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical investigations of some human leukodystrophies.
Ulrich J; Kohler R; Heitz PU; Probst A
Acta Neuropathol; 1983; 60(3-4):199-206. PubMed ID: 6193676
[TBL] [Abstract][Full Text] [Related]
28. Developing treatment options for metachromatic leukodystrophy.
Batzios SP; Zafeiriou DI
Mol Genet Metab; 2012 Jan; 105(1):56-63. PubMed ID: 22078456
[TBL] [Abstract][Full Text] [Related]
29. Case definition and classification of leukodystrophies and leukoencephalopathies.
Vanderver A; Prust M; Tonduti D; Mochel F; Hussey HM; Helman G; Garbern J; Eichler F; Labauge P; Aubourg P; Rodriguez D; Patterson MC; Van Hove JL; Schmidt J; Wolf NI; Boespflug-Tanguy O; Schiffmann R; van der Knaap MS;
Mol Genet Metab; 2015 Apr; 114(4):494-500. PubMed ID: 25649058
[TBL] [Abstract][Full Text] [Related]
30. A correlative synopsis of the leukodystrophies.
Morell P
Neuropediatrics; 1984 Sep; 15 Suppl():62-5. PubMed ID: 6546165
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial dysfunction in central nervous system white matter disorders.
Morató L; Bertini E; Verrigni D; Ardissone A; Ruiz M; Ferrer I; Uziel G; Pujol A
Glia; 2014 Nov; 62(11):1878-94. PubMed ID: 24865954
[TBL] [Abstract][Full Text] [Related]
32. The latest on leukodystrophies.
Schiffmann R; van der Knaap MS
Curr Opin Neurol; 2004 Apr; 17(2):187-92. PubMed ID: 15021247
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy.
Simonis H; Yaghootfam C; Sylvester M; Gieselmann V; Matzner U
Hum Mol Genet; 2019 Jun; 28(11):1810-1821. PubMed ID: 30657900
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for neurodegenerative disorders in children: dreams and realities.
Boespflug-Tanguy O; Sevin C; Piguet F
Arch Pediatr; 2023 Nov; 30(8S1):8S32-8S40. PubMed ID: 38043981
[TBL] [Abstract][Full Text] [Related]
35. Multimodal evoked potential studies in leukodystrophies of children.
De Meirleir LJ; Taylor MJ; Logan WJ
Can J Neurol Sci; 1988 Feb; 15(1):26-31. PubMed ID: 3345458
[TBL] [Abstract][Full Text] [Related]
36. Advances and pitfalls of cell therapy in metabolic leukodystrophies.
Miranda CO; Brites P; Mendes Sousa M; Teixeira CA
Cell Transplant; 2013; 22(2):189-204. PubMed ID: 23006656
[TBL] [Abstract][Full Text] [Related]
37. A study of genetic leukodystrophies in Chinese children.
Wang PJ; Wang TZ; Shen YZ
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(1):44-58. PubMed ID: 1626451
[TBL] [Abstract][Full Text] [Related]
38. Disease specific therapies in leukodystrophies and leukoencephalopathies.
Helman G; Van Haren K; Bonkowsky JL; Bernard G; Pizzino A; Braverman N; Suhr D; Patterson MC; Ali Fatemi S; Leonard J; van der Knaap MS; Back SA; Damiani S; Goldman SA; Takanohashi A; Petryniak M; Rowitch D; Messing A; Wrabetz L; Schiffmann R; Eichler F; Escolar ML; Vanderver A;
Mol Genet Metab; 2015 Apr; 114(4):527-36. PubMed ID: 25684057
[TBL] [Abstract][Full Text] [Related]
39. Astroglia in Leukodystrophies.
Jorge MS; Bugiani M
Adv Exp Med Biol; 2019; 1175():199-225. PubMed ID: 31583590
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
